Across the globe, cases started to rise again at the end of last month, according to the World Health Organization. The number of cases reported worldwide was slightly over 400, with most of the new ones in the Americas and Africa.
to get 25,000 doses of a Japanese-made vaccine initially developed for smallpox to immunize people as part of a clinical trial.
Bavarian Nordic spokesman Rolf Sass Sørensen said the company doesn’t comment on price, but that it does offer differentiated prices to countries. “The vaccine has been sold and distributed to all countries expressing an interest in receiving it,” he said.The success of the vaccination campaign in the U.S. also isn’t helping Africa, where mpox has long been endemic, where the current outbreak originated, and where the next one could emerge.
That’s likely due to the deadlier virus clade circulating in the Democratic Republic of the Congo, which is different from the milder clade that infected people globally. Jynneos is effective against both clades, Bavarian Nordic said. And the number of mpox cases in Africa is most likely an undercount, as many countries still lack the capacity to test for the virus.
The outbreak in African countries has been different in terms of people affected and needs compared to the rest of the world, she said. There, the virus mostly infects heterosexual people, usually in remote areas. But countries like the DRC don’t have the capacity or equipment to test people and keep a close eye on the real number of cases.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Latin America’s bird scientists issue manifesto to end marginalizationTwo new papers “will undoubtedly sensitize” ornithologists from the global north about the challenges facing their colleagues in the south.
Read more »
Mexico rejects possible 'Remain in Mexico' revamp planThe Mexican government said on Monday it had informed the United States that it rejects a possible U.S. re-implementation of an immigration policy known as 'Remain in Mexico,' which required asylum seekers to wait for hearings in Mexico.
Read more »
Mexico opposes restart of U.S. 'Remain in Mexico' immigration policyThe Mexican government said on Monday it is opposed to a possible restart of the U.S. immigration policy known as 'Remain in Mexico' which required asylum seekers to wait for U.S. hearings in Mexico.
Read more »
Mexico opposes restart of U.S. 'Remain in Mexico' immigration policyMEXICO CITY (Reuters) -The Mexican government said on Monday it is opposed to a possible restart of the U.S. immigration policy known as 'Remain in Mexico' which required asylum seekers to wait for U.S. hearings in Mexico. President Joe Biden has sought to end the program, which had been introduced by the Trump administration and is currently suspended. But U.S. states such as Texas and Missouri filed a lawsuit to keep the program active and in December a U.S. judge paused Biden's attempt, saying the Department of Homeland Security had failed to adequately explain why the policy was ineffective and should be scrapped.
Read more »
Mexico rejects any effort to reinstate 'remain in Mexico' policy for asylum-seekersMexico is rejecting any effort to reinstate the Trump-era 'remain in Mexico' policy for asylum-seekers.
Read more »
Mexico rejects any effort to reinstate 'remain in Mexico' policy for asylum-seekersMexico's Ministry of Foreign Affairs said it rejects any effort to reimplement the controversial Trump-era policy known as 'remain in Mexico' for asylum-seekers.
Read more »